2. >>Business

Amphastar Will Receive $59.9m In Momenta/Sandoz Settlement

 
• By Jessica Merrill

The small generics company has talked about using the cash windfall from the expected settlement to fund clinical trials and possibly M&A.

USD Money Cash And Auctioneers Or Judges Gavel Or Hammer On Wooden Courtroom Bench Or Auctioneer Table. Wood Background. Law, Monetary, Auction Bidding, Bankruptcy, Bail, Tax Evasion Concept? - Image
• Source: Shutterstock

Long-standing patent and antitrust litigation between two rivals over the launch of generic enoxaparin (Sanofi's Lovenox) has been settled, with Amphastar Pharmaceuticals Inc. poised to receive $59.9m from Momenta Pharmaceuticals Inc. and Sandoz International GMBH, the companies announced on 19 June.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business